Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancers.

Taylor, Matthew H.; Gainor, Justin F.; Hu, Mimi I.; Zhu, Viola W.; Lopes, Gilberto; Leboulleux, Sophie; Brose, Marcia S.; Schüler, Martin; Bowles, Daniel W.; Kim, Dong‐Wan

doi:10.1200/jco.2019.37.15_suppl.6018

Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancers.

NobleIDNI7P16W23R74S49

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2ABC6DC.svg?ark=w1%2F20260521%2FB2ABC6DC&value=id)](https://nobleid.org/work/w1/20260521/B2ABC6DC)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Activity and tolerability of BLU-667, a highly potent and selective RET inhibitor, in patients with advanced RET-altered thyroid cancers.

NobleIDNI7P16W23R74S49

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/B2ABC6DC.svg?ark=w1%2F20260521%2FB2ABC6DC&value=id)](https://nobleid.org/work/w1/20260521/B2ABC6DC)

ARK Inflections

Metadata (JSON)Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work